Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Moodys

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

X-gen Pharms Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for X-GEN PHARMS INC, and what generic and branded alternatives to X-GEN PHARMS INC drugs are available?

X-GEN PHARMS INC has six approved drugs.



Summary for X-gen Pharms Inc
US Patents:0
Tradenames:6
Ingredients:6
NDAs:6

Drugs and US Patents for X-gen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X-gen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride INJECTABLE;INJECTION 203110-001 Jun 29, 2015 AP RX No No   Start Trial   Start Trial
X-gen Pharms Inc DACTINOMYCIN dactinomycin INJECTABLE;INJECTION 203999-001 May 20, 2019 AP RX No No   Start Trial   Start Trial
X-gen Pharms Inc TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 201580-001 Jun 14, 2013 AP RX No No   Start Trial   Start Trial
X-gen Pharms Inc CLONIDINE HYDROCHLORIDE clonidine hydrochloride INJECTABLE;INJECTION 203167-002 Oct 29, 2013 AP RX No No   Start Trial   Start Trial
X-gen Pharms Inc IBUPROFEN LYSINE ibuprofen lysine INJECTABLE;INTRAVENOUS 202402-001 Mar 30, 2016 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Boehringer Ingelheim
Mallinckrodt
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.